C9orf72 and diabetes mellitus: However, another study in mice with the c9orf72 mutation indicated the type II diabetes medication metformin might have therapeutic potential for ALS (Zu et al., 2020), indicating ALS risk may be moderated differentially across classes of diabetes medication.